{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:02:54Z","timestamp":1791284574609,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Istanbul University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Merkel cell carcinoma (MCC) is diagnosed through histopathological and immunohistochemical examination of biopsies from skin or other organs. Its distinguishing features include perinuclear dot-like staining with Cytokeratin 20 (CK20) and detection of Merkel cell polyomavirus (MCPyV) using various methods. However, CK20 and MCPyV negative MCC cases have been reported at varying rates. In this single center cross-sectional study, we aimed to determine which clones are more effective in diagnosing MCC by comparing the performance of CK20 antibody clones Ks20.8 and SP33, as well as MCPyV antibody clones Ab3 and CM2B4. Fifty-four patients diagnosed with MCC were included. Among these, 42 cases were primary cutaneous, and 12 cases were nodal MCC. Fifty-two (96.3%) cases were positive with both CK20 clones, while two cases were negative. Clone SP33 stained areas of necrosis, whereas Ks20.8 showed no aberrant staining. MCPyV was detected in 44 cases (81.5%) using clone Ab3 and 39 cases (72.2%) using clone CM2B4. Staining with MCPyV clone Ab3 was diffuse and strong in most cases, while approximately 30% of CM2B4-positive cases exhibited low percentages and\/or weak staining, complicating the evaluation. The two CK20-negative cases were also negative with both MCPyV clones. Our data demonstrated that CK20 clone Ks20.8 may be preferred for MCC diagnosis due to its consistent performance and lack of aberrant staining. Similarly, MCPyV clone Ab3 appears superior to CM2B4 for identifying MCPyV-positive cases.<\/jats:p>","DOI":"10.1007\/s12022-024-09845-w","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:10:10Z","timestamp":1737519010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating CK20 and MCPyV Antibody Clones in Diagnosing Merkel Cell Carcinoma"],"prefix":"10.1007","volume":"36","author":[{"given":"Begum","family":"Yeni Erdem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ozluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melin A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Kozanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Saip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesimi","family":"Buyukbabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Ozturk Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"9845_CR1","unstructured":"WHO Classification of Tumours Editorial Board (2023) Skin tumours [Internet; beta version ahead of print]. International Agency for Research on Cancer, Lyon (France)"},{"key":"9845_CR2","doi-asserted-by":"publisher","unstructured":"Youlden DR, Soyer HP, Youl PH, Fritschi L, Baade PD (2014) Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol 150:864-72. https:\/\/doi.org\/10.1001\/jamadermatol.2014.124","DOI":"10.1001\/jamadermatol.2014.124"},{"key":"9845_CR3","doi-asserted-by":"publisher","unstructured":"Fitzgerald TL, Dennis S, Kachare SD, Vohra NA, Wong JH, Zervos EE (2015) Dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States. Am Surg 81:802-6. https:\/\/doi.org\/10.1177\/000313481508100819","DOI":"10.1177\/000313481508100819"},{"key":"9845_CR4","doi-asserted-by":"publisher","unstructured":"van-der-Zwan JM, Trama A, Otter R, Larranaga N, Tavilla A, Marcos-Gragera R, et al. (2013) Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project. Eur J Cancer 49:2565-78. https:\/\/doi.org\/10.1016\/j.ejca.2013.02.029","DOI":"10.1016\/j.ejca.2013.02.029"},{"key":"9845_CR5","doi-asserted-by":"publisher","unstructured":"Reichgelt BA, Visser O (2011) Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer 47:579-85. https:\/\/doi.org\/10.1016\/j.ejca.2010.11.002","DOI":"10.1016\/j.ejca.2010.11.002"},{"key":"9845_CR6","doi-asserted-by":"publisher","unstructured":"Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-100. https:\/\/doi.org\/10.1126\/science.1152586","DOI":"10.1126\/science.1152586"},{"key":"9845_CR7","doi-asserted-by":"publisher","unstructured":"Goh G, Walradt T, Markarov V, Blom A, Riaz N, Doumani R, et al. (2016) Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget 7:3403-15. https:\/\/doi.org\/10.18632\/oncotarget.6494","DOI":"10.18632\/oncotarget.6494"},{"key":"9845_CR8","doi-asserted-by":"publisher","unstructured":"Harms PW, Vats P, Verhaegen ME, Robinson DR, Wu Y-M, Dhanasekaran SM, et al. (2015) The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma. Cancer Res 75:3720-7. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0702","DOI":"10.1158\/0008-5472.CAN-15-0702"},{"key":"9845_CR9","doi-asserted-by":"publisher","unstructured":"Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P (2009) Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 129:246-8. https:\/\/doi.org\/10.1038\/jid.2008.229","DOI":"10.1038\/jid.2008.229"},{"key":"9845_CR10","doi-asserted-by":"publisher","unstructured":"Woodhouse B, Robb TJ, Hearn JI, Houseman PS, Hayward G, Miller R, et al. (2018) Merkel cell polyomavirus is uncommon in New Zealand Merkel cell carcinomas. Br J Dermatol 179:1197-8. https:\/\/doi.org\/10.1111\/bjd.16903","DOI":"10.1111\/bjd.16903"},{"key":"9845_CR11","doi-asserted-by":"publisher","unstructured":"Paik JY, Hall G, Clarkson A, Lee L, Toon C, Colebatch A, et al. (2011) Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Hum Pathol 42:1385-90. https:\/\/doi.org\/10.1016\/j.humpath.2010.12.013","DOI":"10.1016\/j.humpath.2010.12.013"},{"key":"9845_CR12","doi-asserted-by":"publisher","unstructured":"Agelli M, Clegg LX (2003) Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 49:832-41. https:\/\/doi.org\/10.1016\/s0190-9622(03)02108-x","DOI":"10.1016\/s0190-9622(03)02108-x"},{"key":"9845_CR13","doi-asserted-by":"publisher","unstructured":"Schwartz JL, Bichakjian CK, Lowe L, Griffith KA, Frohm ML, Fullen DR, et al. (2013) Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg 39:1009-16. https:\/\/doi.org\/10.1111\/dsu.12194","DOI":"10.1111\/dsu.12194"},{"key":"9845_CR14","doi-asserted-by":"publisher","unstructured":"Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Weaver AL, et al. (2013) Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol 68:433-40. https:\/\/doi.org\/10.1016\/j.jaad.2012.07.035","DOI":"10.1016\/j.jaad.2012.07.035"},{"key":"9845_CR15","doi-asserted-by":"publisher","unstructured":"Kervarrec T, Zaragoza J, Gaboriaud P, Gouge AL, Beby-Defaux A, Corre YL, et al. (2018) Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: the ELECTHIP criteria. J Am Acad Dermatol 78:964-72. https:\/\/doi.org\/10.1016\/j.jaad.2017.11.037","DOI":"10.1016\/j.jaad.2017.11.037"},{"key":"9845_CR16","doi-asserted-by":"publisher","unstructured":"Broida SE, Chen XT, Baum CL, Brewer JD, Block MS, Jakub JW, et al. (2022) Merkel cell carcinoma of unknown primary: clinical presentation and outcomes. J Surg Oncol 126:1080-6. https:\/\/doi.org\/10.1002\/jso.27010","DOI":"10.1002\/jso.27010"},{"key":"9845_CR17","doi-asserted-by":"publisher","unstructured":"Bellizzi AM (2013) Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol 20:285-314. https:\/\/doi.org\/10.1097\/PAP.0b013e3182a2dc67","DOI":"10.1097\/PAP.0b013e3182a2dc67"},{"key":"9845_CR18","doi-asserted-by":"publisher","unstructured":"Miner AG, Patel RM, Wilson DA, Procop GW, Minca EC, Fullen DR, et al. (2015) Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod Pathol 28:498-504. https:\/\/doi.org\/10.1038\/modpathol.2014.148","DOI":"10.1038\/modpathol.2014.148"},{"key":"9845_CR19","doi-asserted-by":"publisher","unstructured":"Busam KJ, Jungbluth AA, Rekthman N, Coit D, Pulitzer M, Bini J, et al. (2009) Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 33:1378-85. https:\/\/doi.org\/10.1097\/PAS.0b013e3181aa30a5","DOI":"10.1097\/PAS.0b013e3181aa30a5"},{"key":"9845_CR20","doi-asserted-by":"publisher","unstructured":"Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, et al. (2019) Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma. Mod Pathol 32:1605-16. https:\/\/doi.org\/10.1038\/s41379-019-0288-7","DOI":"10.1038\/s41379-019-0288-7"},{"key":"9845_CR21","doi-asserted-by":"publisher","unstructured":"Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, et al. (2017) Polyomavirus-negative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection. J Invest Dermatol 137:819-27. https:\/\/doi.org\/10.1016\/j.jid.2016.10.028","DOI":"10.1016\/j.jid.2016.10.028"},{"key":"9845_CR22","doi-asserted-by":"publisher","unstructured":"Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, et al. (2019) Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas. Mod Pathol 32:499-510. https:\/\/doi.org\/10.1038\/s41379-018-0155-y","DOI":"10.1038\/s41379-018-0155-y"},{"key":"9845_CR23","doi-asserted-by":"publisher","unstructured":"Mendoza MD, Santonja C, Gonzalez-Vela C, Concha A, Iglesias-Pena N, Andres-Esteban EM, et al. (2020) The presence of Merkel cell carcinoma polyomavirus is associated with a distinct phenotype in neoplastic Merkel cell carcinoma cells and their tissue microenvironment. PLoS One 15:e0232517. https:\/\/doi.org\/10.1371\/journal.pone.0232517","DOI":"10.1371\/journal.pone.0232517"},{"key":"9845_CR24","doi-asserted-by":"publisher","unstructured":"Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, Schrama D (2009) MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 129:248-50. https:\/\/doi.org\/10.1038\/jid.2008.198","DOI":"10.1038\/jid.2008.198"},{"key":"9845_CR25","doi-asserted-by":"publisher","unstructured":"Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, et al. (2009) Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125:1243-9. https:\/\/doi.org\/10.1002\/ijc.24510","DOI":"10.1002\/ijc.24510"},{"key":"9845_CR26","doi-asserted-by":"publisher","unstructured":"Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 17:4806-13. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3363","DOI":"10.1158\/1078-0432.CCR-10-3363"},{"key":"9845_CR27","doi-asserted-by":"publisher","unstructured":"Rodig SJ, Cheng J, Wardzala J, DoRosario A, Scanlon JJ, Laga AC, et al. (2012) Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 122:4645-53. https:\/\/doi.org\/10.1172\/JCI64116","DOI":"10.1172\/JCI64116"},{"key":"9845_CR28","doi-asserted-by":"publisher","unstructured":"Pelletier DJ, Czeczok TW, Bellizzi AM (2018) A monoclonal antibody against SV40 large T antigen (PAb416) does not label Merkel cell carcinoma. Histopathology 73:162-6. https:\/\/doi.org\/10.1111\/his.13483","DOI":"10.1111\/his.13483"},{"key":"9845_CR29","doi-asserted-by":"publisher","unstructured":"Starrett GJ, Thakuria M, Chen T, Marcelus C, Cheng J, Nomburg J, et al. (2020) Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med 12. https:\/\/doi.org\/10.1186\/s13073-020-00727-4","DOI":"10.1186\/s13073-020-00727-4"},{"key":"9845_CR30","doi-asserted-by":"publisher","unstructured":"Arora R, Rekhi B, Chandrani P, Krishna S, Dutt A (2019) Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. Microb Pathog 137. https:\/\/doi.org\/10.1016\/j.micpath.2019.103778","DOI":"10.1016\/j.micpath.2019.103778"},{"key":"9845_CR31","unstructured":"Moll R, Lowe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-47."},{"key":"9845_CR32","doi-asserted-by":"publisher","unstructured":"Ferrandiz-Pulido C, Gomez-Tomas A, Llombart B, Mendoza D, Marcoval J, Piaserico S, et al. (2022) Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort study. J Eur Acad Dermatol Venereol 36:1991-2001. https:\/\/doi.org\/10.1111\/jdv.18256","DOI":"10.1111\/jdv.18256"},{"key":"9845_CR33","doi-asserted-by":"publisher","unstructured":"La-Rosa S, Bonzini M, Sciarra A, Asioli S, Maragliano R, Arrigo M, et al. (2020) Exploring the prognostic role of Ki67 proliferative index in Merkel cell carcinoma of the skin: clinico-pathologic analysis of 84 cases and review of the literature. Endocr Pathol 31:392-400. https:\/\/doi.org\/10.1007\/s12022-020-09640-3","DOI":"10.1007\/s12022-020-09640-3"},{"key":"9845_CR34","doi-asserted-by":"publisher","unstructured":"Foulongne V, Kluger N, Dereure O, Brieu N, Guillot B, Segondy M (2008) Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 14:1491-3. https:\/\/doi.org\/10.3201\/eid1409.080651","DOI":"10.3201\/eid1409.080651"},{"key":"9845_CR35","doi-asserted-by":"publisher","unstructured":"Alvarez-Arguelles ME, Melon S, Rojo S, Fernandez-Blazquez A, Boga JA, Palacio A, et al. (2017) Detection and quantification of Merkel cell polyomavirus. Analysis of Merkel cell carcinoma cases from 1977 to 2015. J Med Virol 89:2224-9. https:\/\/doi.org\/10.1002\/jmv.24896","DOI":"10.1002\/jmv.24896"},{"key":"9845_CR36","doi-asserted-by":"publisher","unstructured":"Kuwamoto S, Higaki H, Kanai K, Iwasaki T, Sano H, Nagata K, et al. (2011) Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma. Hum Pathol 42:632-40. https:\/\/doi.org\/10.1016\/j.humpath.2010.09.011","DOI":"10.1016\/j.humpath.2010.09.011"},{"key":"9845_CR37","doi-asserted-by":"publisher","unstructured":"Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, et al. (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105:16272-7. https:\/\/doi.org\/10.1073\/pnas.0806526105","DOI":"10.1073\/pnas.0806526105"},{"key":"9845_CR38","doi-asserted-by":"publisher","unstructured":"Gjoerup O, Chang Y (2010) Update on human polyomaviruses and cancer. Adv Cancer Res 106:1-51. https:\/\/doi.org\/10.1016\/S0065-230X(10)06001-X","DOI":"10.1016\/S0065-230X(10)06001-X"},{"key":"9845_CR39","doi-asserted-by":"publisher","unstructured":"Urso C, Pierucci F, Sollai M, Arvia R, Massi D, Zakrzewska K (2016) Detection of Merkel cell polyomavirus and human papillomavirus DNA in porocarcinoma. J Clin Virol 78:71-3. https:\/\/doi.org\/10.1016\/j.jcv.2016.03.008","DOI":"10.1016\/j.jcv.2016.03.008"},{"key":"9845_CR40","doi-asserted-by":"publisher","unstructured":"Leroux-Kozal V, Leveque N, Brodard V, Lesage C, Dudez O, Makeieff M, et al. (2015) Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. Hum Pathol 46:443-53. https:\/\/doi.org\/10.1016\/j.humpath.2014.12.001","DOI":"10.1016\/j.humpath.2014.12.001"},{"key":"9845_CR41","doi-asserted-by":"publisher","unstructured":"Komatsu H, Usui Y, Sukeda A, Yamamoto Y, Ohno S-I, Goto K, et al. (2023) Prevalence of Merkel cell polyomavirus in primary eyelid Merkel cell carcinomas and association with clinicopathological features. Am J Ophthalmol 249:49-56. https:\/\/doi.org\/10.1016\/j.ajo.2022.12.001","DOI":"10.1016\/j.ajo.2022.12.001"},{"key":"9845_CR42","doi-asserted-by":"publisher","unstructured":"Harms PW, Collie AMB, Hovelson DH, Cani AK, Verhaegen ME, Patel RM, et al. (2016) Next generation sequencing of cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation. Mod Pathol 29:240-8. https:\/\/doi.org\/10.1038\/modpathol.2015.154","DOI":"10.1038\/modpathol.2015.154"},{"key":"9845_CR43","doi-asserted-by":"publisher","unstructured":"Haneke E (1985) Electron microscopy of Merkel cell carcinoma from formalin-fixed tissue. J Am Acad Dermatol 12:487-92. https:\/\/doi.org\/10.1016\/s0190-9622(85)70068-0","DOI":"10.1016\/s0190-9622(85)70068-0"},{"key":"9845_CR44","doi-asserted-by":"publisher","unstructured":"Topalian SL, Bhatia S, Amin A, Kudchadkar RR, Sharfman WH, Lebbe C, et al. (2020) Neoadjuvant nivolumab for patients with resectable Merkel cell carcinoma in the CheckMate 358 trial. J Clin Oncol 38:2476-87. https:\/\/doi.org\/10.1200\/JCO.20.00201","DOI":"10.1200\/JCO.20.00201"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09845-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-024-09845-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09845-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:25:41Z","timestamp":1767860741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-024-09845-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9845"],"URL":"https:\/\/doi.org\/10.1007\/s12022-024-09845-w","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"29 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at Istanbul Faculty of Medicine, Istanbul University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1"}}